
Overview
Cardinal Pharma is a leading distributor of pharmaceutical, cosmetic, and food raw materials with over 30 years of experience. The company specializes in the distribution of chemical substances and raw materials, supporting clients with a wide range of specialized services.
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 5 of 6 financial statements were filed late (the longest delay 355 days for 2019). 5 of 6 audited by a statutory auditor.
- 2025not filed
- 202408/08/2025
- 202311/09/2024
- 202202/11/2023
- 202102/11/2022
- 202030/09/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.
Results vs industry
Industry
Offer
- Pharmaceutical substances
- Cosmetic raw materials
- Food raw materials
- Raw material distribution
- Specialist services
Websites
- cardinalpharma.euCardinal Pharma S.A. - wiodący dystrybutor substancjiGoogle AnalyticsGoogle Tag ManagerCloudflare
Trademarks
The company holds 1 active trademark registered with the Polish Patent Office. The first mark was filed in 2023.
| Mark | Protected until | |
|---|---|---|
| LA DOTTA GELATERIA | Sep 22, 2033 |
Authorized Representatives
Manner of representation
Each member of the management board is authorised to submit declarations of will on behalf of the company independently.
Supervisory board
Beneficial owners
| Person | Rights |
|---|---|
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
Pharmbridge sp. z o.o. | 450.21 USD | 33.3333% |
Bank accounts
Registered as a VAT taxpayer on 1993-07-05.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
18 public aid cases recorded, with a total value of $167,496.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Mar 12, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | –– | Prezes Banku Gospodarstwa Krajowego | |
| Jan 7, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | –– | PGE Obrót S.A. | |
| Mar 13, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | –– | Prezes Banku Gospodarstwa Krajowego |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Keyser & Mackay Polska sp. z o.o. | $15,137,850.02 | keysermackay.com | ||
| POL-NIL sp. z o.o. | $9,170,055.52 | pol-nil.com.pl | ||
| Kaczmarek-Komponenty sp. z o.o. | $6,395,002.97 | kaczmarek-komponenty.pl | ||
| Delog sp. z o.o. | $4,968,862.92 | delog.pl | ||
| Impag Chemicals Poland sp. z o.o. | $4,704,802.39 | impag.com | ||
| Enzym Kosmetyki sp. z o.o. | $4,027,361.46 | enzym.com.pl | ||
| Nortrade Pharma sp. z o.o. | $3,904,334.77 | nortradepharma.com | ||
| Medicos sp. z o.o. | $2,712,576.27 | medicos.com.pl | ||
| Actifarm sp. z o.o. | $2,151,476.85 | actifarm.pl | ||
| Centro-Chem sp. z o.o. | $2,077,483.81 | centro-chem.pl |
Change history
| Date | Event | |
|---|---|---|
| 2019-04-16 | Switch to PKD 2007 (43 PKD 2004 codes → 9 PKD 2007 codes) | |
| 2012-10-12 | Share capital increase (500,000.00 PLN → 2,655,000.00 PLN) | |
| 2012-06-06 | Address change (Piotrkowska 130, 90-062, Łódź → Gen. J.sowińskiego 5a, 91-485, Łódź) | |
| 2011-12-13 | Name change ("hand" → "cardinal Pharma") | |
| 2009-09-17 | PKD change (Added: 11.01.Z, 11.07.Z, 46.34.A, 46.34.B, 47.25.Z) |
FAQ
Last updated: 2026-10-13
